A comparative study of anti-leukemic effects of kaempferol and epigallocatechin-3-gallate (EGCG) on human leukemia HL-60 cells | ||
Avicenna Journal of Phytomedicine | ||
دوره 11، شماره 4، مهر و آبان 2021، صفحه 314-323 اصل مقاله (826.47 K) | ||
نوع مقاله: Short communication | ||
شناسه دیجیتال (DOI): 10.22038/ajp.2021.17604 | ||
نویسندگان | ||
Mohammad Hassan Jokar؛ Sima Sedighi؛ Maliheh Moradzadeh* | ||
Golestan Rheumatology Research Center, Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran | ||
چکیده | ||
Objective: Acute promyelocytic leukemia (APL) is among the most threatening hematological malignant cancers. Defects in cell growth and apoptotic pathways lead to the pathogenesis of the disease as well as its resistance to therapy; therefore, it is a good candidate for examining pro-apoptotic agents. The present study compared the molecular mechanism induced by kaempferol and epigallocatechin gallate (EGCG) as well as all-trans retinoic acid (ATRA) in HL-60 leukemia cells during five days. Materials and Methods: Cell viability was determined by resazurin assay following treatment with ATRA (10 µM), EGCG, and kaempferol (12.5-100 µM), and apoptosis was detected by the Anx V/PI kit. Moreover, the levels of genes involved in apoptosis (PI3K, AKT, BCL2, BAX, P21, PTEN, CASP3, CASP8, and CASP9) and multi-drug resistance (ABCB1 and ABCC1) were assessed by using real-time PCR test. Results: Based on the findings, kaempferol decreased cell viability and increased apoptosis in HL60 cells more than EGCG. Apoptosis was induced via extrinsic and intrinsic pathways in HL60 cells by kaempferol and EGCG. In addition, kaempferol and EGCG increased apoptosis and inhibited MDR in a concentration- and time-dependent manner. Conclusion: Kaempferol at high concentrations can be taken into consideration for treating patients with APL as compared with EGCG. | ||
کلیدواژهها | ||
APL؛ Kaempferol؛ EGCG؛ Apoptosis؛ MDR | ||
مراجع | ||
Adams J, Nassiri M. 2015. Acute promyelocytic leukemia: a review and discussion of variant translocations. Arch Pathol Lab Med, 139: 1308-1313. Alonso-Castro AJ, Ortiz-Sánchez E, GarcíaRegalado A, Ruiz G, Núñez-Martínez JM, González-Sánchez I, Quintanar-Jurado V, Morales-Sánchez E, Dominguez F and López-Toledo G. 2013. Kaempferitrin induces apoptosis via intrinsic pathway in HeLa cells and exerts antitumor effects. J Ethnopharmacol, 145: 476-489. Benyahia S, Benayache S, Benayache F, Quintana J, López M, León F, Hernández JC, Estévez F and Bermejo J. 2004. Isolation from eucalyptus o ccidentalis and identification of a new Kaempferol EGCG and kaempherol's effects in APL AJP, Vol. 11, No. 4, Jul-Aug 2021 321 derivative that induces apoptosis in human myeloid leukemia cells. J Nat Prod, 67: 527-531. Cardinale L, Asteggiano F, Moretti F, Torre F, Ulisciani S, Fava C and Rege-Cambrin G. 2014. Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome. World J Radiol, 6: 583-588. Chung SY, Jang DS, Han AR, Jang JO, Kwon Y, Seo EK, Lee HJ. 2007. Modulation of P‐ glycoprotein‐ mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet. Phytother Res, 21: 565- 569. Da J, Xu M, Wang Y, Li W, Lu M and Wang Z. 2019. Kaempferol promotes apoptosis while inhibiting cell proliferation via androgen-dependent pathway and suppressing vasculogenic mimicry and invasion in prostate cancer. Anal Cell Pathol, 2019: 1-10. El-Kott A, Shati A, Al-Kahtani M, Alharbi S. 2020. Kaempferol induces cell death in A2780 ovarian cancer cells and increases their sensitivity to cisplatin by activation of cytotoxic endoplasmic reticulum-mediated autophagy and inhibition of protein kinase B. Folia Biol, 66: 36-46. Gupta S, Hussain T, Mukhtar H. 2003. Molecular pathway for (−)- epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys, 410: 177-185. Gyemant N, Tanaka M, Antus S, Hohmann J, Csuka O, Mandoky L, Molnár J. 2005. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. In vivo, 19: 367-374. Hosseini A, Ghorbani A. 2015. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed, 5: 84-97. Kanadaswami C, Lee L-T, Lee P-PH, Hwang JJ, Ke F-C, Huang Y-T, Lee M-T. 2005. The antitumor activities of flavonoids. In Vivo, 19: 895-909. Kang HJ, Youn Y-K, Hong M-K, Kim LS. 2011. Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals. J Korean Med Sci, 26: 893-899. Kashafi E, Moradzadeh M, Mohamadkhani A, Erfanian S. 2017. Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways. Biomed Pharmacother , 89: 573- 577. Khan N, Adhami VM, Mukhtar H. 2010. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer, 17: R39-R52. Kitagawa S, Nabekura T, Takahashi T, Nakamura Y, Sakamoto H, Tano H, Hirai M, Tsukahara G. 2005. Structure–activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull, 28: 2274-2278. Kuete V, Ango PY, Yeboah SO, Mbaveng AT, Mapitse R, Kapche GD, Ngadjui BT and Efferth T. 2014. Cytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines. BMC Complement Altern Med, 14: 340-347. Li M, Liu J-T, Pang X-M, Han C-J, Mao J-J. 2012. Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced Creactive protein production in macrophages. Pharmacol Rep, 64: 912- 918. Limtrakul P, Khantamat O, Pintha K. 2005. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother, 17: 86-95. Luo H, Daddysman MK, Rankin GO, Jiang BH, Chen YC. 2010. Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int, 10: 1-9. Luo H, Rankin GO, Li Z, DePriest L, Chen YC. 2011. Kaempferol induces apoptosis in Jokar et al. AJP, Vol. 11, No. 4, Jul-Aug 2021 322 ovarian cancer cells through activating p53 in the intrinsic pathway. Food chem, 128: 513-519. Ly BTK, Chi HT, Yamagishi M, Kano Y, Hara Y, Nakano K, Sato Y, Watanabe T. 2013. Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells. PLoS One, 8: e66378. Lyn-Cook BD, Rogers T, Yan Y, Blann EB, Kadlubar FF, Hammons GJ. 1999. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer, 35: 80-86. Mashkani B, Tanipour MH, Saadatmandzadeh M, Ashman LK, Griffith R. 2016. FMS-like tyrosine kinase 3 (FLT3) inhibitors: Molecular docking and experimental studies. Eur J Pharmacol, 776: 156-166. Mei Y, Wei D, Liu J. 2005. Reversal of multidrug resistance in KB cells with tea polyphenol antioxidant capacity. Cancer Biol Ther, 4: 474-479. Moradzadeh M, Hosseini A, Erfanian S, Rezaei H. 2017. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase. Pharmacol Rep, 69: 924-928. Moradzadeh M, Roustazadeh A, Tabarraei A, Erfanian S, Sahebkar A. 2018. Epigallocatechin‐3‐gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML‐RAR α and HDAC1. Phytother Res, 32: 471- 479. Moradzadeh M, Sadeghnia HR, Tabarraei A, Sahebkar A. 2017. Anti-tumor effects of crocetin and related molecular targets. J Cell Physiol, 233: 2170-2182. Moradzadeh M, Tabarraei A, Sadeghnia HR, Ghorbani A, Mohamadkhani A, Erfanian S, Sahebkar A. 2018. Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes. J of cell biochem, 119: 2288-2297. Nakamura Y, Chang C-C, Mori T, Sato K, Ohtsuki K, Upham BL and Trosko JE. 2005. Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis, 26: 665-671. Nowakowska A, Tarasiuk J. 2016. Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells. Acta Biochim Pol, 63: 571-575. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK. 2012. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell proliferation, 45: 487-498. Pal D, Mitra AK. 2006. MDR-and CYP3A4- mediated drug–herbal interactions. Life sci, 78: 2131-2145. Pallis M, Turzanski J, Higashi Y, Russell N. 2002. P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype. Leuk Lymphoma, 43: 1221-1228. Pfaffl MW. 2006. Relative quantification. Realtime PCR, 63: 63-82. Pitha-Rowe I, Petty W, Kitareewan S, Dmitrovsky E. 2003. Retinoid target genes in acute promyelocytic leukemia. Leukemia, 17: 1723-1730. Qian F, Wei D, Zhang Q, Yang S. 2005. Modulation of P-glycoprotein function and reversal of multidrug resistance by (–)- epigallocatechin gallate in human cancer cells. Biomed Pharmacother, 59: 64-69. Rangarajan P, Subramaniam D, Paul S, Kwatra D, Palaniyandi K, Islam S, Harihar S, Ramalingam S, Gutheil W, Putty S. 2015. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Oncotarget, 6: 27661-27673. Santos BL, Oliveira MN, Coelho PL, Pitanga BP, da Silva AB, Adelita T, Silva VDA, de FD Costa M, El-Bachá RS, Tardy M. 2015. Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, EGCG and kaempherol's effects in APL AJP, Vol. 11, No. 4, Jul-Aug 2021 323 migration, and by regulating extracellular matrix proteins and metalloproteinases expression. Chem Biol Interact, 242: 123- 138. Shaffer BC, Gillet J-P, Patel C, Baer MR, Bates SE, Gottesman MM. 2012. Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updates, 15: 62-69. Shu L, Cheung K-L, Khor TO, Chen C, Kong A-N. 2010. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer and Metastasis Rev, 29: 483-502. Thielecke F, Boschmann M. 2009. The potential role of green tea catechins in the prevention of the metabolic syndrome–a review. Phytochemistry, 70: 11-24. To KK, Yu L, Liu S, Fu J, Cho CH. 2012. Constitutive AhR activation leads to concomitant ABCG2‐mediated multidrug resistance in cisplatin‐resistant esophageal carcinoma cells. Mol carcinog, 51: 449- 464. Tu LY, Bai HH, Cai JY, Deng SP. 2016. The mechanism of kaempferol induced apoptosis and inhibited proliferation in human cervical cancer SiHa cell: From macro to nano. Scanning, 38: 644-653. Wang J, Xie Ya, Feng Y, Zhang L, Huang X, Shen X, Luo X. 2015. (-)- Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation. Int J Oncol, 46: 1507-1515. Wen Y, Zhao R-Q, Zhang Y-K, Gupta P, Fu LX, Tang A-Z, Liu B-M, Chen Z-S, Yang DH, Liang G. 2017. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells. Oncotarget, 8: 29760. Xiao J, Ho CT, Liong EC, Nanji AA, Leung TM, Lau TYH, Fung ML, Tipoe GL. 2014. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in nonalcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr, 53: 187-199. Xu W, Liu J, Li C, Wu H-Z, Liu Y-W. 2008. Kaempferol-7-O-β-d-glucoside (KG) isolated from Smilax china L. rhizome induces G 2/M phase arrest and apoptosis on HeLa cells in a p53-independent manner. Cancer lett, 264: 229-240. Yang CS, Landau JM, Huang M-T, Newmark HL. 2001. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr, 21: 381-406. Zhou J, Farah BL, Sinha RA, Wu Y, Singh BK, Bay B-H, Yang CS, Yen PM. 2014. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One, 9: e87161. | ||
آمار تعداد مشاهده مقاله: 7,023 تعداد دریافت فایل اصل مقاله: 679 |